Lyra Therapeutics, Inc. Profile Avatar - Palmy Investing

Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo techn…

Biotechnology
US, Watertown [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Lyra Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Lyra Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Lyra Therapeutics, Inc..

End of LYRA's Analysis
CIK: 1327273 CUSIP: 55234L105 ISIN: US55234L1052 LEI: - UEI: -
Secondary Listings
LYRA has no secondary listings inside our databases.